AstraZeneca India to launch centres of excellence for severe asthma in Delhi, Ahmedabad, Kochi and Goa
The Centers of Excellence for severe asthma, as per the guidelines established by the Global Initiative for Asthma, would concentrate on specialty and clinical assessment, diagnosis, patient counselling, biologics initiation, and data management related to severe asthma.;
Advertisement
New Delhi: UK drugmaker AstraZeneca's India arm has announced plans to launch five centres of excellence across the country to provide a systematic approach to standardised and uniform management of patients with severe asthma.
The centres, to be set up one each in the national capital, Ahmedabad, Kochi and two in Goa, will serve as the exemplar hub for treatment and management of severe asthma patients, the company said in a statement on World Asthma Day.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.